This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

APOTECAchemo™ Surpasses 18 Months Of Continuous Use In The United States, Demonstrating Excellent Safety, Efficiency And Cost Control

NASHVILLE, Tenn., March 19, 2013 /PRNewswire/ -- The first two installations of Apoteca in the United States took place at the Cleveland Clinic and Wake Forest University Baptist Medical CenterCleveland Clinic's implementation plan included a lengthy review and approval by the Ohio Board of Pharmacy. Both facilities deployed Apoteca in busy oncology centers serving both inpatients and outpatients.  Daily production includes complex doses that require reconstitution, multiple vials, bags requiring final volume adjustment, and products requiring delicate handling, like monoclonal agents.

Next month, the University of Maryland Medical System will take delivery and install the next Apoteca.  The University of Maryland joins the number of worldwide pharmacies in active daily production with APOTECAchemo™, where safety, efficiency, workload relief and cost reduction are being realized in one elegant package.

Another critically important achievement at Cleveland Clinic was the activation of an HL-7 interface with Epic's healthcare information system, eliminating duplicate entry and the related risk of transcription errors.   Wake Forest will deploy a similar interface to Epic.

Production has continued to grow, reaching about 75% to 80% of daily volume, and is expected to increase further, as seen in other Apoteca installations making over 100 doses per day.  Each site chooses from nearly 60 chemical entities and 300 different vials supported by Apoteca, allowing the selection of products that provide maximum benefit.  Apoteca's flexibility has also helped protect against drug shortages by efficiently switching to alternate sources. 

Importantly, Apoteca is supported by an experienced service organization with more than 25 years of success in industrial engineering, healthcare and robotics, resulting in documented up-time percentages of 98.5% or higher.  Excellent support and product maturity also makes installation easier than one might think.  At Wake Forest , for example, installation from loading dock to making initial patient doses took fewer than 30 days.

Confidence continues to grow in Apoteca's onboard patient and staff safety features.  Apoteca includes the scientific elements of other standalone products using balances, scanners and cameras for validation and documentation.  It promotes staff safety and cost control through physical separation of humans from the compounding process, without requiring certain closed system transfer devices.  This elimination represents a cost-saving opportunity of $10.00 to $12.00 per dose.

For more information please visit:  www.ApotecaUSA.com

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs